Navigation Links
Bioethics Commission calls for enhanced federal oversight in new field of synthetic biology

Washington, DC The Presidential Commission for the Study of Bioethical Issues today released its first reporta wide-ranging review of the emerging field of synthetic biologyissuing 18 recommendations including a call for coordinated federal oversight of scientists working in both large institutions and smaller settings.

The panel, comprised of 13 scientists, ethicists, and public policy experts, said that the very newness of the science, which involves the design and construction of laboratory-made biological parts, gives regulators, ethicists and others time to identify any problems early on and craft solutions that can harness the technology for the public good.

"We comprehensively reviewed the developing field of synthetic biology to understand both its potential rewards and risks," said Dr. Amy Gutmann, the Commission Chair and President of the University of Pennsylvania. "We considered an array of approaches to regulationfrom allowing unfettered freedom with minimal oversight and another to prohibiting experiments until they can be ruled completely safe beyond a reasonable doubt. We chose a middle course to maximize public benefits while also safeguarding against risks."

Dr. Gutmann said the Commission's approach recognizes the great potential of synthetic biology, including life saving medicines, and the still distant risks posed by the field. "Prudent vigilance suggests that federal oversight is needed and can be exercised in a way that is consistent with scientific progress," she said.

President Obama asked the Commission to study the implications of synthetic biology following the May 20 announcement by the J. Craig Venter Institute that it had inserted a laboratory-made genome into a bacterial cell, creating an organism not found in nature. In three public hearings held over the past five months in Washington, D.C., Philadelphia, and Atlanta, the Commission heard from over three-dozen ethicists, scientists and others close to the issue and considered a range of possible actions the government could take to prevent problems that might occur in the future.

Several experts explored potential benefits of synthetic biology, including the development of vaccines and new drugs and the production of biofuels that could someday reduce the need for fossil fuels. Discussions addressed the risks posed by the technology, including the inadvertent release of a laboratory-created organism into nature and the potential adverse effects of such a release on ecosystems. To reduce any possible threat, some scientists and ethicists advised careful monitoring and review of the research.

The Commission concluded that while the technical challenges of synthetic biology remain daunting, the field is likely to become more decentralized as the relevant tools become increasingly available and affordable-a change that may pose novel challenges with regard to oversight

"While the 'Do-It-Yourself' community has an important role to play in advancing synthetic biology, we recognize that technical challenges and costs are too high right now for a completely novel organism to be developed in a non-institutional setting," said Dr. James W. Wagner, Commission Vice Chair and President of Emory University. "We strongly support an open dialogue between DIY groups and the government as we go forward so that scientists and government can discuss the research constraints necessary to protect public safety as the field continues to evolve."

The Commission recommended the following steps in order to minimize risks and to foster innovation:

  • The Executive Office of the President, possibly through the Office of Science and Technology Policy, should coordinate federal agencies that oversee areas related to synthetic biology, including oversight, product licensing and funding.

  • Risk assessment activities across the government need to be coordinated and field release permitted only after reasonable risk assessment.

  • The Executive Office of the President should remain actively engaged with "do it yourself" groups to communicate and discuss applicable safety and security issues.

  • Recognizing that international coordination is essential for safety and security, the Department of State, in concert with the Department of Health and Human Services and the Department of Homeland Security, should collaborate with governments around the world, as well as leading international organizations, such as the World Health Organization to promote ongoing dialogue about emerging technologies like synthetic biology.

  • The National Institutes of Health, the Department of Energy and other federal agencies should evaluate research proposals through peer-review in order to make sure that the most promising scientific research is conducted on the public's behalf.

  • Educational classes on the ethical dilemmas raised by synthetic biology should be a mandatory part of training for young researchers, engineers, and others who work in this emerging field.

  • Forums should be established to improve the general public's understanding of this field, including the creation of a biology equivalent to, in which a private group would track statements about the science and offer an independent view of the truth of such claims.

Dr. Gutmann noted that the issues considered are relevant well beyond government officials and emphasized the value of informed public conversation regarding scientific research.

"The public, journalists, and policymakers need facts and reliable analyses to help them understand the benefits as well as the risks of new technologies," said Gutmann. "To aid public understanding of emerging scientific issues, the Commission is recommending that an independent organization do for synthetic biology and biotechnology what does for politicsbe an online resource to check the truthfulness of prominent claims and criticisms about new scientific discoveries and help spur informed discussion."


Contact: Jemma Weymouth
Burness Communications

Related biology news :

1. Overcoming Taboos, Myths, and Dogmas in Bioethics
2. March of Dimes establishes 2 new perinatal bioethics awards
3. Bioethics beach reading, Summer 2010 edition
4. 4 essays look at the next generation of bioethics
5. NOAA and NSF commission national study of ocean acidification
6. North American environmental commission launches trinational vaquita conservation plan
7. Tuna Commission to decide the future of Mediterranean bluefin
8. End of the line for Tuna Commission
9. Another fisheries commission throws the science overboard in tuna decision, WWF says
10. CWRU receives $5 million from Ohio Third Frontier Commission
11. Statement of ESHRE on the European Commission proposal of viral screening
Post Your Comments:
(Date:11/12/2015)... 12, 2015  Arxspan has entered into an ... Harvard for use of its ArxLab cloud-based suite ... The partnership will support the institute,s efforts to ... research information internally and with external collaborators. The ... managing the Institute,s electronic laboratory notebook, compound and ...
(Date:11/9/2015)... 2015 ... "Global Law Enforcement Biometrics Market 2015-2019" ... ) has announced the addition ... Market 2015-2019" report to their offering. ... ) has announced the addition of ...
(Date:10/29/2015)... 29, 2015  The J. Craig Venter Institute (JCVI) ... Synthesis and Biosecurity: Lessons Learned and Options for the ... and Human Services guidance for synthetic biology providers has ... --> --> Synthetic biology ... potential to pose unique biosecurity threats. It now is ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... , Nov. 24, 2015 HemoShear Therapeutics, ... discovering drugs for metabolic disorders, announced today the ... its Board of Directors (BOD). Mr. Watkins is ... Human Genome Sciences (HGS), and also served as ... Jim Powers , Chairman and CEO of ...
(Date:11/24/2015)... , November 24, 2015 , ... a European healthcare fund ... companies will work closely together in identifying European breakthrough technologies ... need. The collaboration is underpinned by a significant investment by ... is the first investment by Bristol-Myers Squibb in a European ...
(Date:11/24/2015)... YORK , Nov. 24, 2015 According to ... than in 2005. This is something that many doctors, scientists, ... time. One questions remains: with fewer PSA tests being done, ... ? Dr. David Samadi, "Despite the ... the disease remains the second leading cancer cause of death ...
(Date:11/23/2015)... 23, 2015   Ceres, Inc . (Nasdaq: ... results for the fiscal year ended August 31, 2015 ... --> --> During fiscal year ... feed products with a better balance of yield, energy ... agreements with several leading crop input providers and made ...
Breaking Biology Technology: